Latest filing published 04 Jun 2026 for Bioventus Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Martin P. Sutter, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Abiomed Inc and Bioventus Inc. Over a trading history stretching from 31 December 2015 to 2 June 2026, the count stands at 86 filings.
Every open-market trade on record is a sale: 46 sales worth €27.3M. The rest of the record consists of 23 share grants and 10 option exercises.
On 4 June 2026 came the latest disclosure, an option exercise in Bioventus Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations